As such, our identification of TGIF1 as a potential oncogene in LUAD that interacts with ELF3 and EHF provides an unprecedented SE-associated CRC model for future identification and investigation of these potential targets amenable to therapeutic intervention in LUAD. This evidence concerns the gene EHF and colorectal carcinoma.